Dr. Mathios is developing and validating a liquid biopsy approach that detects early genetic and epigenetic features of cancer and could reduce unnecessary high-risk invasive procedures.
Dr. Mathios is developing and validating a liquid biopsy approach that detects early genetic and epigenetic features of cancer and could reduce unnecessary high-risk invasive procedures.